Pinning Down the EGF Receptor  by Jovin, Thomas M.
Biophysical Journal Volume 107 December 2014 2486–2488 2486New and NotablePinning Down the EGF
Receptor
Thomas M. Jovin1,*
1Laboratory of Cellular Dynamics, Max
Planck Institute for Biophysical Chemistry,
Go¨ttingen, Germany
According to leading investigators in
the field of cellular signal transduction,
the epidermal growth factor (EGF)
receptor (EGFR, ErbB1, HER1), ubiq-
uitously encountered in signaling
mechanisms and thus in human tu-
mors, is the best studied yet least pro-
totypic of receptor tyrosine kinases in
general (1). This perception arises pri-
marily from the fact that activation
of the EGFR is thought to be confor-
mational/allosteric, i.e., not requiring
covalent modifications at or near the
active site (2). However, a number
of outstanding, perplexing questions
exist that might still place the EGFR
in the well known but poorly under-
stood category. Delineating these is-
sues requires an outline of the current
dogma.
The EGFR monomer is a glycosy-
lated transmembrane protein, compris-
ing an ectodomain with the capacity
of adopting a ligand (growth factor)-
binding conformation; a single-pass
transmembrane domain with distinct
bilateral juxtamembrane segments;
and a cytoplasmic domain containing
a latent tyrosine kinase core and a
C-terminus with nine tyrosine residues
serving as phosphorylation targets. In
response to ligand (e.g., EGF) binding,
although also in its absence under
certain conditions, the EGFR forms
homodimers and heterodimers with
the three other members of the HER
family. As a consequence, the kinase
domain(s) auto- and trans-phosphory-
late the C-terminal tail(s). The pYhttp://dx.doi.org/10.1016/j.bpj.2014.10.037
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tion elements funneling directly or
indirectly via adaptor proteins into
downstream intracellular signaling
pathways, including Ras/Raf/MEK/
ERK1/2, phosphatidylinositol 3-kinase
(PI3K)/Akt, and phospholipase C
(PLCg). In most cases, membrane
translocation and recycling of one or
more components is involved.
Let us regard the same system from
a biophysical perspective, posing
certain questions (Q1–Q9, listed
below) for which answers are as yet
incomplete. I propose defining the
EGFR as a ‘‘multifaceted signal trans-
ducer’’. Signaling is bidirectional with
respect to the plasma (or endosomal)
membrane, mediated by interactions
with the classical peptidic growth fac-
tors as well as with other regulatory
molecules (proteins, individual lipids,
lipid microdomains, carbohydrates).
Concerted (Q1) reactions couple
ligand binding (Q2) to conformational
transitions (Q3) leading to formation
(or reconfiguration) of a dimer (Q4)
stabilized by the extension and inter-
twining of dimerization arms; the
interactions can be homotypic and
heterotypic. The ectodomain—and as
a consequence, the kinase subdo-
mains—adopt active configurations
(Q5). The primary targets of phosphor-
ylation are the C-terminus of the same
and/or partner EGFR monomer (Q6)
but other cellular proteins are also
phosphorylated (Q7). EGFR signaling
is abrogated by phosphatases (Q8)
before and after clathrin-dependent
cellular uptake.
In view of these considerations, I
deem it expedient to invoke four
distinct activated states or entities of
the EGFR: i), ectodomain configu-
ration(s); ii), the phosphorylated
carboxy-terminal tail; iii), the activated
kinase(s); and iv), monomeric or
oligomeric derivatives of the primary
activation dimer. The complex inter-
play of thermodynamic states and
complexes, and the corresponding ki-
netic parameters at steady state or full
equilibrium are of primary importance.For example, the external ‘‘clasps’’ and
internal (juxtamembranar) ‘‘latches’’
presumably stabilize dimers for only
a finite time, as evidenced in single-
molecule tracking experiments (3).
This aspect of the EGFR system is
further complicated by the identifi-
cation, already in 1993, of numerous
factors leading to aggregation and
thus activation of the EGFR by non-
canonical mechanisms (Q9). Mass ac-
tion (molecular crowding) suffices to
induce EGFR kinase activity, even if
the interactions are unspecific and/or
polymorphic. Thus, EGFR activation
can be achieved or enhanced by protein
modification, high expression levels,
focal ligand exposure (functionalized
microbeads and nanoparticles), coag-
gregation with protein and peptidic
kinase substrates, interaction with pol-
yaminoacids and polyamines, and the
targeted application of physical forces.
The influences of the lipid environ-
ment (4) are undoubtedly key but as
yet not fully elucidated, for example
in relation to feedback and feedfor-
ward regulation (5).
Q1: Is a rigorous biophysical defini-
tion in terms of distinct states
(conformational, complexation,
association) possible at this time?
Q2: How many molecules? Is there
negative and/or positive binding
cooperativity? Role of nonspe-
cific (physical) factors?
Q3: Involving which distinct states of
the tripartite molecule?
Q4: Role of preformed dimer? Sym-
metric versus asymmetric?; 1 or
2 ligands?
Q5: Mechanism of transmembrane
crosstalk? Does reciprocal con-
formational inhibition and activa-
tion of the ecto- and endodomains
occur? What are the influences
of ligand identity and EGFR
subcellular compartmentalization
(plasma membrane, endosomes,
filopodia, nucleus)?
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vated in the dimer? What deter-
mines a (the) particular pattern of
tyrosine modification? Random?
Q7: How many? How can (large) pro-
tein substrates be accommodated
stereochemically by a dimer?
Q8: How long do the other activated
states persist before and after? For
example, is a dissociated, C-termi-
nally phosphorylated monomer
active in signal transduction?
Q9: What is the relative influence
of ligand-dependent and ligand-
independent processes on the
distribution of EGFR and its
downstream signaling partners?
A number of these issues are ad-
dressed in an intriguing new study of
the output interface(s) of the EGFR
from the Baird-Holowka group at
Cornell University (6). The authors
inverted the usual ligand-to-EGFR
experimental paradigm by generating
an ordered micron-sized array of EGF
on silicon surfaces, using techniques
honed in numerous long-standing
studies of FcεRI. A parylene-patterned
silicon substrate with 1.5-4 mm features
was functionalized with Alexa568-
streptavidin and incubated with EGF-
biotin. Removal of the parylene yielded
defined patterns of bound EGF, which
were readily recognized by NIH-3T3
cells overexpressing the EGFR depos-
ited on the surface (unfortunately,
neither the number of receptors per
cell nor the density of immobilized
EGF was specified). The images pre-
sented indicate that there were <10
EGF domains per overlying cell. The
activation of EGFR was determined
immunocytochemically as EGFR-pY.
Multiprotein EGFR signaling com-
plexes formed at the plasma membrane
in response to the micropatterned
EGF and the images were subjected to
correlation and distribution analyses.
Immobilized EGF has been used
previously to study the influences
of ligand density and diffusion barriers
on the degree of activation of EGFR
((7) and references therein; (8)).
Stabley et al. (8) demonstrated thatclustering of the EGFR required phos-
phorylation to a degree that was
inversely related to cluster size, as
well as interaction with one or more
forms of F-actin. Singhai et al. (6)
exploited the micropatterned EGF to
obtain much more detailed information
about the correlated spatiotemporal
distribution of activated EGFR, down-
stream effectors, and certain molecules
involved in cell-cell and cell-extra-
cellular matrix interactions. The initial
step of receptor recruitment to the EGF
patches occurred in 10–40 min at
37C; the authors attribute this very
long time course primarily to the ac-
commodation of the cell to the surface
and secondarily to ligand density and
accessibility. However, inasmuch as
the association of EGF to the streptavi-
din surface-coupling agent is revers-
ible in principle, one can ask whether
the EGF molecules can (must) detach
and redistribute to fully populate
EGFR dimers in such an experimental
system (Q2); this process would be
very slow. Phosphorylation (pY-1068)
accompanied cellular attachment and
EGFR clustering, and was inhibited
by the kinase inhibitor Iressa. How-
ever, Iressa did not inhibit the clus-
tering per se, a clear demonstration
that ligand binding and many of its
consequences can be uncoupled from
kinase function (to be distinguished
from kinase activation; Q2–Q5). Paxil-
lin, a component of integrin-mediated
signaling at focal adhesions, was also
recruited to the clusters of activated
EGFR and underwent phosphoryla-
tion, although not by EGFR but prob-
ably by Src, which modulates EGFR
function via phosphorylation at Tyr-
845. Is compartmentalization required
for this process (Q5)? F-actin and in-
tegrin a5b1 were likewise corecruited,
in the latter case preferentially to sites
at the cell periphery. Could unliganded
mobile phosphorylated monomers be
involved (Q8)? In the case of the
Erk signaling pathway, EGFP-labeled
H-Ras and N-Ras concentrated at
the EGF patches, as did the down-
stream effectors MEK and pErk. The
phenomena were physiological in thatthe latter molecules underwent subse-
quent translocation to the nucleus.
Other upstream members of this
signaling cascade (Grb2, Shc, SOS,
Raf), were not monitored. Their rela-
tive stoichiometry in the EGFR-over-
expressing cells would be important,
inasmuch as their physical recruitment
would have to antecede that of MEK
and pErk.
An additional finding was the inhibi-
tion by cytochalasin D of the recruit-
ment of paxillin and pErk, but not of
the GTPase dynamin 2, a mediator of
EGFR endocytosis. Does the involve-
ment of F-actin imply the need for
sequestration of scaffold and 14-3-3
proteins, which regulate the kinetics,
strength and position of MEK/ERK
signaling? Interestingly, PLCg1, an
enzyme responsible for hydrolysis
of PI(4,5)P2, was also recruited to
the patterned EGF, and inhibition of
PI(4,5)P2 biosynthesis suppressed the
recruitment of F-actin and pErk. The
demonstration that phosphoinositides
are involved in the stabilization of
signaling complexes by F-actin is
novel and important (4), as is the
evidence of a differential distribution
of focal adhesion components and
F-actin, with implications for down-
stream signaling involved in cell
migration.
The conclusion one can derive from
the impressive study from the Baird-
Holowka lab is that the spatial distribu-
tion of signaling entities is orchestrated
by a hierarchy of local and external
factors, starting with the input and
output interfaces mediating activa-
tion of the EGFR (Q9) and other
members of the HER family. One can
conceive of biophysical extensions to
address Q2–Q5. Assessing recruitment
and kinase activation as a function of
the density of immobilized EGF would
be very instructive. Photocleavable
attachment of the EGF to the micropat-
terned surfaces would enable assess-
ment of diffusion-dependent and
dissociation processes. Optogenetic
control of gene expression and molec-
ular states could greatly enhance the
scope of the imaging based analyses.Biophysical Journal 107(11) 2486–2488
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would permit isolation of individual
stages in sequential responses. Single-
molecule techniques (3), including
those based on fluorescence resonance
energy transfer, lifetime, and hyper-
spectral signatures, should also be
feasible and instructive. From a cell
biological standpoint, one would wish
to study other cell types and assess
the processes of EGFR endocytosis
and recycling.
The bottom line? After 31 years, the
EGFR (and Q1) remain elusive.but
within reach.Biophysical Journal 107(11) 2486–2488REFERENCES
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